hydrochlorothiazide has been researched along with Developmental Disabilities in 2 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Neonatal hypoglycemia is one of the most common biochemical abnormalities encountered in the newborn." | 2.50 | Update on neonatal hypoglycemia. ( Rozance, PJ, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rozance, PJ | 1 |
de Vries, TW | 1 |
van der Veer, E | 1 |
Heijmans, HS | 1 |
1 review available for hydrochlorothiazide and Developmental Disabilities
Article | Year |
---|---|
Update on neonatal hypoglycemia.
Topics: Biosensing Techniques; Blood Glucose; Developmental Disabilities; Diazoxide; Diuretics; Female; Gluc | 2014 |
1 other study available for hydrochlorothiazide and Developmental Disabilities
Article | Year |
---|---|
Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
Topics: Acenocoumarol; Bone and Bones; Developmental Disabilities; Drug Combinations; Female; Fetal Diseases | 1993 |